Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Mixed-Methods Open-Label Trial Evaluating the Effects of Neuralli® MP on Self-Defined Outcomes in Adults With Autistic Traits

NCT07064538 is registered in ClinicalTrials.gov with Mackay Memorial Hospital as lead sponsor.

NCT NCT07064538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07064538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Mixed-Methods Open-Label Trial Evaluating the Effects of Neuralli® MP on Self-Defined Outcomes in Adults With Autistic Traits
Lead sponsor
Mackay Memorial Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 19, 2025
Completion date
August 31, 2026
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asd, autism, autistic disorders spectrum